Alaunos Therapeutics (TCRT) Payables (2016 - 2025)
Historic Payables for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to $843000.0.
- Alaunos Therapeutics' Payables rose 8406.11% to $843000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $843000.0, marking a year-over-year increase of 8406.11%. This contributed to the annual value of $516000.0 for FY2024, which is 1623.38% down from last year.
- Alaunos Therapeutics' Payables amounted to $843000.0 in Q3 2025, which was up 8406.11% from $809000.0 recorded in Q2 2025.
- Alaunos Therapeutics' Payables' 5-year high stood at $4.2 million during Q1 2021, with a 5-year trough of $365000.0 in Q2 2024.
- Over the past 5 years, Alaunos Therapeutics' median Payables value was $843000.0 (recorded in 2025), while the average stood at $1.1 million.
- Its Payables has fluctuated over the past 5 years, first surged by 95808.08% in 2021, then crashed by 8556.09% in 2022.
- Alaunos Therapeutics' Payables (Quarter) stood at $1.4 million in 2021, then increased by 1.54% to $1.4 million in 2022, then crashed by 55.65% to $616000.0 in 2023, then dropped by 16.23% to $516000.0 in 2024, then soared by 63.37% to $843000.0 in 2025.
- Its Payables stands at $843000.0 for Q3 2025, versus $809000.0 for Q2 2025 and $831000.0 for Q1 2025.